Although the transcription factor c-Myc is essential for the establishment of a metabolically active and proliferative state in T cells after priming, its expression is transient. It remains unknown how T cell activation is maintained after c-Myc expression is downregulated. Here we identified AP4 as the transcription factor that was induced by c-Myc and sustained activation of antigen-specific CD8+ T cells. Despite normal priming, AP4-deficient CD8+ T cells failed to continue transcription of a broad range of c-Myc-dependent targets. Mice lacking AP4 specifically in CD8+ T cells showed enhanced susceptibility to infection with West Nile virus. Genome-wide analysis suggested that many activation-induced genes encoding molecules involved in metabolism were shared targets of c-Myc and AP4. Thus, AP4 maintains c-Myc-initiated cellular activation programs in CD8+ T cells to control microbial infection.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Cancer Gene Therapy Open Access 06 July 2022
AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p
Molecular Cancer Open Access 27 May 2022
Nature Communications Open Access 09 May 2019
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Gene Expression Omnibus
Kaech, S.M. & Wherry, E.J. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27, 393–405 (2007).
Zhang, N. & Bevan, M.J. CD8+ T cells: foot soldiers of the immune system. Immunity 35, 161–168 (2011).
Chang, C.H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239–1251 (2013).
Kaech, S.M. & Cui, W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12, 749–761 (2012).
MacIver, N.J., Michalek, R.D. & Rathmell, J.C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259–283 (2013).
van der Windt, G.J. & Pearce, E.L. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol. Rev. 249, 27–42 (2012).
Wang, R. & Green, D.R. Metabolic reprogramming and metabolic dependency in T cells. Immunol. Rev. 249, 14–26 (2012).
Kim, J. et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 143, 313–324 (2010).
Nie, Z. et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151, 68–79 (2012).
Lin, C.Y. et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151, 56–67 (2012).
Rahl, P.B. et al. c-Myc regulates transcriptional pause release. Cell 141, 432–445 (2010).
Sinclair, L.V. et al. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14, 500–508 (2013).
Wang, R. et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871–882 (2011).
Kaech, S.M. & Ahmed, R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2, 415–422 (2001).
Prlic, M., Hernandez-Hoyos, G. & Bevan, M.J. Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response. J. Exp. Med. 203, 2135–2143 (2006).
Blair, D.A. et al. Duration of antigen availability influences the expansion and memory differentiation of T cells. J. Immunol. 187, 2310–2321 (2011).
Porter, B.B. & Harty, J.T. The onset of CD8+-T-cell contraction is influenced by the peak of Listeria monocytogenes infection and antigen display. Infect. Immun. 74, 1528–1536 (2006).
Best, J.A. et al. Transcriptional insights into the CD8+ T cell response to infection and memory T cell formation. Nat. Immunol. 14, 404–412 (2013).
Williams, M.A., Tyznik, A.J. & Bevan, M.J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 441, 890–893 (2006).
Obar, J.J. et al. CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses. Proc. Natl. Acad. Sci. USA 107, 193–198 (2010).
D'Souza, W.N. & Lefrancois, L. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J. Immunol. 171, 5727–5735 (2003).
Kalia, V. et al. Prolonged interleukin-2Rα expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32, 91–103 (2010).
Pipkin, M.E. et al. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32, 79–90 (2010).
Egawa, T. & Littman, D.R. Transcription factor AP4 modulates reversible and epigenetic silencing of the Cd4 gene. Proc. Natl. Acad. Sci. USA 108, 14873–14878 (2011).
Hu, Y.F., Luscher, B., Admon, A., Mermod, N. & Tjian, R. Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev. 4, 1741–1752 (1990).
Mermod, N., Williams, T.J. & Tjian, R. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 332, 557–561 (1988).
Pircher, H., Burki, K., Lang, R., Hengartner, H. & Zinkernagel, R.M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342, 559–561 (1989).
Maekawa, Y. et al. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nat. Immunol. 9, 1140–1147 (2008).
Yoon, H., Kim, T.S. & Braciale, T.J. The cell cycle time of CD8+ T cells responding in vivo is controlled by the type of antigenic stimulus. PLoS ONE 5, e15423 (2010).
Petersen, L.R. & Fischer, M. Unpredictable and difficult to control–the adolescence of West Nile virus. N. Engl. J. Med. 367, 1281–1284 (2012).
Suthar, M.S., Diamond, M.S. & Gale, M. Jr. West Nile virus infection and immunity. Nat. Rev. Microbiol. 11, 115–128 (2013).
Shrestha, B. & Diamond, M.S. Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 78, 8312–8321 (2004).
Wang, R. & Green, D.R. Metabolic checkpoints in activated T cells. Nat. Immunol. 13, 907–915 (2012).
Jung, P., Menssen, A., Mayr, D. & Hermeking, H. AP4 encodes a c-MYC-inducible repressor of p21. Proc. Natl. Acad. Sci. USA 105, 15046–15051 (2008).
Huang, C.Y.B.A.L., Walker, L.M., Bassing, C.H. & Sleckman, B.P. Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse. Eur. J. Immunol. 38, 342–349 (2008).
van der Windt, G.J. et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36, 68–78 (2012).
Lovén, J. et al. Revisiting global gene expression analysis. Cell 151, 476–482 (2012).
Chang, D.W., Claassen, G.F., Hann, S.R. & Cole, M.D. The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Mol. Cell. Biol. 20, 4309–4319 (2000).
Yeh, E. et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 6, 308–318 (2004).
de Alboran, I.M. et al. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14, 45–55 (2001).
Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661–665 (2007).
Zehn, D., Lee, S.Y. & Bevan, M.J. Complete but curtailed T-cell response to very low-affinity antigen. Nature 458, 211–214 (2009).
Hogquist, K.A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17–27 (1994).
Mombaerts, P. et al. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 360, 225–231 (1992).
Willerford, D.M. et al. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521–530 (1995).
Morita, S., Kojima, T. & Kitamura, T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063–1066 (2000).
Bolstad, B.M., Irizarry, R.A., Astrand, M. & Speed, T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185–193 (2003).
Ciofani, M. et al. A validated regulatory network for Th17 cell specification. Cell 151, 289–303 (2012).
Langmead, B. & Salzberg, S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576–589 (2010).
We thank M.J. Bevan (University of Washington, Seattle) for LM-OVA; I. Taniuchi (RIKEN, Yokohama) and D.R. Littman (New York University) for CD8-Cre mice; B.P. Sleckman (Washington University School of Medicine) for c-Myc–GFP knock-in mice; F.W. Alt (Harvard Medical School) and D.R. Green (St. Jude Children's Research Hospital) for MycF mice; T. Hansen (Washington University School of Medicine) for the H-2Kb–OVA single-chain tetramer; S. Hsiung, J. Govero and M.J. Sunshine for technical assistance; and E. Oltz, C.-S. Hsieh and D.R. Littman for discussions and critical reading of the manuscript. Supported by the Lucille P. Markey Pathway Program (C.C.), the Burroughs Wellcome Fund (B.T.E.), the McDonnell International Scholars Academy at Washington University (C.-C.L.), the US National Institutes of Health (P30 AR048335 to the Rheumatic Diseases Core Center; R01 AI097244 to T.E.; and U54 AI081680 to M.S.D.), the Edward Mallinckrodt Jr. Foundation (T.E.) and the Washington University Institute of Clinical and Translational Sciences of the National Center for Advancing Translational Sciences of the US National Institutes of Health (UL1 TR000448).
The authors declare no competing financial interests.
Integrated supplementary information
Supplementary Figure 1 AP4 is required in a cell-autonomous way for the population expansion of CD8+ T cells.
(a) A gene-targeting strategy shown with representative restriction enzyme sites used for screening by Southern blot with a 5’ external probe (gray square). LoxP sites were inserted to flank exons 2 to 4 of Tfap4 in ES cells. The loxP-neo cassette was deleted in vitro by transient Cre transfection in ES cells prior to blastocyst injection. (b) Quantitative RT-PCR analysis of RNA of CD4+ and CD8+ T cells purified from Tfap4F/F Cre– or Tfap4F/F CD8-Cre+ mice showing the abundance of the transcript encoding Tfap4. Error bars, s.d. (n = 3) (c,d) Flow cytometry analysis showing expression of CD4, CD8α, KLRG1, CD62L and H-2Db–gp(33–41)-specific TCR in peripheral blood mononuclear cells (PBMC) from Tfap4–/– (n = 7), Tfap4F/F CD8-Cre+ (n = 7) and control C57BL/6 mice (n = 15) on day 8 after LCMV-Arm infection. Statistical analysis is shown in (d). Each symbol in d represents an individual mouse; small horizontal lines indicate the mean (± s.d.). * P < 0.05, ** P < 0.01, *** P < 0.001, NS: not significant by unpaired t-test (b) or one-way ANOVA (d). Data pooled from three experiments.
Supplementary Figure 2 AP4 is required for the population expansion of antigen-specific CD8+ T cells in response to infection with LM-OVA.
(a) Flow cytometry analysis showing expression of CD8α, KLRG1, CD62L and H2-Kb–OVA-specific TCR in splenocytes of Tfap4–/– and age-matched C57BL/6 mice on day 7 after LM-OVA infection. OVA-specific CD8+ T cells, and KLRG1+ CD62L– effectors and KLRG1– CD62L+ memory precursors are shown with rectangular gates with percentages. (b) Statistical analysis of total, KLRG1+ and CD62L+ H2-Kb–OVA-specific CD8+ T cells. (n = 6 for C57BL/6, 8 for Tfap4–/– mice in two independent experiments). (c) Statistical analysis of ratios between Tfap4–/– and Tfap4+/+ OT-I T cells. (n = 15 for day 3, 18 for day 4, 6 for day 5, 8 for day 6, 8 for day 7). (d) Statistical analysis of percentages of BrdU+ OT-I T cells following 2 h pulse labeling. (n = 9 for day 3, 5 for day 4, 7 for day 5, 6 for day 6, 8 for day 7). (e) Flow cytometry analysis of OT-I T cells showing levels of phosphorylated serine 235/236 of S6 ribosomal protein (p-S6) on day 4 after LM-OVA infection shown as histogram overlays. (n = 5). (f) Statistical analysis of ratios of Tfap4–/– and Tfap4+/+ OT-I T cells co-cultured with OVA peptide-pulsed irradiated splenocytes. Percentages of Tfap4–/– OT-I cells in total OT-I T cells are shown. (g) Flow cytometry analysis of Tfap4–/– and Tfap4+/+ OT-I T cells showing FSC after co-culture in the presence of irradiated splenocytes pulsed with 0.1 nM of OVA peptide. (n = 3). (h) Statistical analysis of percentages of IFN-γ-producing Tfap4–/– and Tfap4+/+ OT-I cells that had been initially activated by anti-CD3 and anti-CD28 and re-stimulated with OVA-peptide pulsed irradiated splenocytes. Values were normalized to the maximum percentage of cells producing IFN-γ. (n = 2). (i) Statistical analysis of LM-OVA bacterial titers in spleens and livers of Tfap4F/F CD8-Cre+ and Tfap4F/F Cre– mice on days 4 and 6 after infection. (n = 4 for Tfap4F/F Cre–, 6 for Tfap4F/F CD8-Cre+ in two experiments). Error bars, s.d. Each symbol represents an individual mouse; small horizontal lines indicate the mean (± s.d.). * P < 0.05, ** P < 0.01, *** P < 0.001, NS: not significant by unpaired t-test. Data are representative of three experiments (a-d), two experiments (e-i).
Supplementary Figure 3 AP4 is essential for the secondary population expansion of memory CD8+ T cells.
(a) Flow cytometry analysis of splenocytes showing expression of CD8α, CD127, CD62L and H-2Db–gp(33–41)-specific TCR on day 60 after LCMV-Arm infection. (n = 4). (b,c) Statistical analysis of absolute numbers of gp(33–41)-specific total memory CD8+ T cells and CD62L+ central memory CD8+ T cells in the spleen on day 60 after LCMV-Arm infection (b) and frequencies of gp(33–41)-specific memory CD8+ T cells in peripheral blood mononuclear cells (PBMC) in Tfap4–/– (n = 6), Tfap4F/F CD8-Cre+ (n = 7) or control C57BL/6 mice (n = 14) on day 60 after LCMV-Arm infection (c). (d) IFN-γ ELISPOT assay showing frequencies of OVA-specific memory CD8+ T cells in splenocytes of Tfap4–/– (n = 4) and control C57BL/6 mice (n = 4) on day 45 after LM-OVA infection. All mice had less than 11 spots per million splenocytes when no antigen was included. (e,f) Flow cytometry analysis showing expression of CD8α, CD45.2, CD62L, KLRG1 and H-2Db–gp(33–41)-specific TCR in splenocytes of CD45.1 wild-type host mice on day 5 after LCMV-Arm infection. Before infection, the host mice received CD8+ T cells from Tfap4–/– or C57BL/6 mice, which were infected with LCMV-Arm 60 days before. (n = 8 in two independent experiments). Statistical analysis is shown in (f). (g) Flow cytometry analysis of PBMC of Tfap4–/– (n = 15), Tfap4F/F CD8-Cre+ (n = 9), or control C57BL/6 mice (n = 14) 5 days after secondary challenge with LM-OVA. (h) Statistical analysis of numbers of total CD8+ T cell and OVA-specific CD8+ T cells numbers in blood and spleen 5 days after secondary challenge with LM-OVA is shown. Each symbol represents an individual mouse; small horizontal lines indicate the mean (± s.d.). * P < 0.01, ** P < 0.001, *** P < 0.0001, NS: not significant by unpaired t-test (b,d,f) or one-way ANOVA (c,h). Data are representative of three experiments.
Supplementary Figure 4 AP4 is required for the population expansion of antigen-specific CD8+ T cells after infection with WNV.
Statistical analysis showing absolute numbers of total CD8+ T cells (a), H-2Db–NS4B-specific T cells as determined by H-2Db–NS4B tetramer binding (b) or intracellular staining for IFN-γ following NS4B peptide stimulation (c) in the spleen on day 7 after WNV infection. Data is from one experiment using five Tfap4–/–, four Tfap4F/F CD8-Cre+, and four control age- and sex-matched C57BL/6 mice. * P < 0.05, NS: not significant by Mann Whitney U-test. Each symbol represents an individual mouse; small horizontal lines indicate median.
Supplementary Figure 5 AP4 is required for maintenance of T cell activation during acute CD8+ T cell responses.
(a) Quantitative RT-PCR and immunoblot analysis showing c-Myc and AP4 expression at mRNA and protein levels in CD8+ T cells following stimulation with anti-CD3 and anti-CD28. (n = 2). (b) Flow cytometry of CD8+ T cells from OT-I Mycc-Myc–GFP/+ mice showing c-Myc–GFP expression after two-hour stimulation with anti-CD3 and anti-CD28 and quantitative RT-PCR analysis of transcripts encoding Myc or Tfap4 in purified GFPLo and GFPHi cells. (n = 2). (c) Quantitative PCR analysis of anti-c-Myc immunoprecipitated chromatin of activated CD8+ T cells showing enrichment of the Tfap4 intronic fragments containing c-Myc consensus binding sequences. PCR primers for Cd4 promoter (Cd4Pro), Hoxa13 promoter (Hoxa13) and Cd4 silencer (Cd4Sil) were used as negative control (n = 2). (d) Flow cytometry of CD8+ T cells showing FSC in the naive state and following 24 h stimulation with anti-CD3 and anti-CD28 antibodies in vitro. (n = 3). (e) ECAR measurement showing glycolytic rates of Tfap4–/– and C57BL/6 CD8+ T cells after stimulation with anti-CD3 and anti-CD28 for 24 h. Data represent three independent experiments with three to four biological replicates in each experiment. (f) qRT-PCR analysis of RNA from CD8+ T cells showing 18S rRNA-normalized expression of Myc, Hif1a and genes encoding glycolytic enzymes at different time points following stimulation with anti-CD3 and anti-CD28 antibodies in vitro. (n = 3). (g) Flow cytometry of co-transferred Tfap4–/– and Tfap4+/+ P14 T cells showing FSC after infection of recipient mice with LCMV-Arm. Representative histogram overlays at each time point are shown in the left panel. (n = 3). (h) Microarray gene expression analysis of C57BL/6 CD8+ T cells in the naive state, or after activation with anti-CD3 and anti-CD28 in vitro for 3 days (n = 2), and OT-I T cells 2 days after LM-OVA infection in vivo (n = 3). Expression levels of the 479 AP4/Myc co-regulated genes identified in Fig. 6f are shown by a heat map. Expression levels are normalized to those of naive CD8+ T cells. Error bars, s.d. Each symbol in g represents an individual mouse; small horizontal lines indicate the mean (± s.d.).* P < 0.05, ** P < 0.01, NS: not significant by one-way ANOVA (b), unpaired t-test (e) or paired t-test (g). Data are representative of two experiments (a-c,f), three experiments (d-g), and one experiment (h).
Supplementary Figure 6 ChIP-sequencing analysis identifies AP4 and c-Myc target genes in CD8+ T cells.
(a-d) Annotation and motif analysis of genomic sequences bound by AP4 (a,b) or c-Myc (c,d) in activated C57BL/6 CD8+ T cells. (e) Examples of AP4 and c-Myc binding to genes that are differently expressed between Tfap4–/– and Tfap4+/+ OT-I T cells in vivo. BedGraph histograms are shown with statistically significant peaks as red rectangles. P < 1 × 10-10 for anti-AP4 ChIP, P < 5 × 10-9 for anti-c-Myc ChIP by Poisson distribution. ChIP-seq data for RNA polymerase II C-terminal domain (polII-CTD) serine phosphorylations (S2P and S5P) are shown as reference to transcribed regions. Data are from one experiment.
(a) An experimental scheme to retrovirally express AP4 in Myc-deficient CD8+ T cells. MycF/+Cre– (Myc+/+) or Myc+/+Rosa26-Cre-ERT2 and MycF/FRosa26-Cre-ERT2 (Myc–/– after 4OHT treatment) CD8+ T cells were transduced with empty-, FLAG-tagged AP4-, or Myc-expressing RV after activation with anti-CD3 and anti-CD28 for 24 h, and subsequently cultured in media containing IL-7 (10 ng/ml) and 4-hydroxytamoxifen (4OHT, 500 nM) for 2 days. Transduced cells (GFP+) were sorted, labeled with the division-tracking dye CellTraceTM Violet (CTV), and restimulated with anti-CD3 and anti-CD28 for two days. (b) Immunoblot showing c-Myc and AP4 expression 48 h after re-stimulation under the same conditions. n = 2. (c) Quantitative RT-PCR analysis showing the abundance of transcripts encoding Myc, Tfap4, or Il2ra after re-stimulation for 2 h. (n = 3). (d) Flow cytometry showing CTV fluorescence and FSC of RV-transduced Myc+/+, Myc+/+ Cre-ERT2(+) and Myc–/– CD8 T cells shown as histogram overlays. (n = 3). (e) Microarray analysis of Myc+/+ and Myc–/– CD8+ T cells transduced with AP4- or c-Myc-expressing RV shown as a heat map. Genes that were differently expressed by >2-fold between EV-transduced Myc+/+ and Myc–/– cells are shown with the abundance normalized to Myc+/+ + EV samples. Datasets were analyzed by hierarchical clustering using Euclidean distance matrix with average linkage. (n = 2). Error bars, s.d. * P < 0.0001, NS: not significant by one-way ANOVA. Data are representative of two experiments.
About this article
Cite this article
Chou, C., Pinto, A., Curtis, J. et al. c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells. Nat Immunol 15, 884–893 (2014). https://doi.org/10.1038/ni.2943
This article is cited by
Cancer Gene Therapy (2023)
AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p
Molecular Cancer (2022)
Nature Immunology (2022)
Nature Reviews Urology (2020)
The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc
Nature Immunology (2019)